Skip to main content
. 2021 Oct 28;10(1):e42–e51. doi: 10.1016/S2214-109X(21)00448-4

Figure 2.

Figure 2

Probability of efficacy and Bayesian relative risk of hospitalisation defined as either retention in a COVID-19 emergency setting or transfer to tertiary hospital due to COVID-19 for fluvoxamine versus placebo

BCI=Bayesian credible interval.